Platelet-derived growth factor expression and stimulation in human meningiomas

Area of Science:

• Oncology
• Molecular Biology
• Cell Signaling

Background:

• Meningiomas are primary tumors of the central nervous system.
• The platelet-derived growth factor (PDGF) family plays a role in cell growth and development.
• The role of PDGF-BB in meningioma pathogenesis is not fully understood.

Purpose of the Study:

• To investigate the expression of PDGF family members in meningiomas.
• To determine the effect of exogenous PDGF-BB on meningioma cell growth.
• To examine the functional activity of the PDGF-beta receptor in meningiomas.

Main Methods:

• Northern blot analysis of PDGF-A, PDGF-B, PDGF-alpha receptor, and PDGF-beta receptor mRNA expression in 20 meningioma tissues.
• In vitro culture of 10 human meningioma cell lines to assess growth response to PDGF-BB using tritiated thymidine incorporation.
• Western blot analysis to detect c-fos proto-oncogene induction by PDGF-BB.

Main Results:

• All meningioma samples expressed PDGF-A and PDGF-B mRNA. PDGF-beta receptor mRNA was detected in 19 out of 20 tumors, while PDGF-alpha receptor mRNA was not detected.
• Exogenous PDGF-BB significantly stimulated meningioma cell proliferation in 3 out of 10 tested specimens, with a 3- to 6-fold increase in thymidine incorporation.
• PDGF-BB induced a significant increase in c-fos protein levels in meningioma cell cultures within 3 hours, indicating functional PDGF-beta receptor activation.

Conclusions:

• Meningiomas express PDGF-A, PDGF-B subunits, and functional PDGF-beta receptors.
• PDGF-BB acts as a growth factor for a subset of meningiomas.
• These findings support the hypothesis that PDGF signaling contributes to meningioma development and progression.